http://orcid.org/0000-0002-7869-1564
References
- De Sanctis V, Kattamis C, Canatan D, et al. β-Thalassemia distribution in the Old World: an ancient disease seen from a historical standpoint. Mediterr J Hematol Infect Dis. 2017;9(1):e2017018.
- Rezaee AR, Banoei MM, Khalili E, Houshmand M. β-Thalassemia in Iran: new insight into the role of genetic admixture and migration. ScientificWorldJournal. 2012;2012:635183.
- Moradi G, Ghaderi E. Chronic disease program in Iran: thalassemia control program. Chron Dis J. 2013;1(2):98–106.
- Adler NE, Stewart J. Preface to the biology of disadvantage: socioeconomic status and health. Ann NY Acad Sci. 2010;1186:1–4.
- Braveman P, Egerter S, Williams DR. The social determinants of health: coming of age. Annu Rev Public Health. 2011;32:381–398.
- Kaplan GA, Shema SJ, Leite CM. Socioeconomic determinants of psychological well-being: the role of income, income change, and income sources during the course of 29 years. Ann Epidemiol. 2008;18(7):531–537.
- Keshavarz-Moahmmadi N. Social determinants of health. Health promotion, and sustainable development goals: rising opportunities in Iran to address SDH and achieve SDGs. Social Behav Res Health (SBRH). 2017;1(1):1–2.
- Koch CG, Li L, Kaplan GA, et al. Socioeconomic position, not race, is linked to death after cardiac surgery. Circ Cardiovasc Qual Outcomes. 2010;3(3):267–276.
- Marmot M. Achieving health equity: from root causes to fair outcomes. Lancet. 2007;370(9593):1153–1163.
- Braveman P, Gottlieb L. The social determinants of health: it’s time to consider the causes of the causes. Public Health Rep. 2014;129(1 Suppl 2):19–31.
- Krumeich A, Meershoek A. Health in global context; beyond the social determinants of health? Glob Health Action. 2014;7:23506.
- Joulaei H, Shabazi M, Nazemzadegan B, et al. The diminishing trend of β-thalassemia in Southern Iran from 1997 to 2011: the impact of preventive strategies. Hemoglobin. 2014;38(1):19–23.
- Hashemieh M, Timori Naghadeh H, Tabrizi Namini M, et al. The Iran Thalassemia Prevention Program: success or failure? Iran J Ped Hematol Oncol. 2015;5(3):161–166.
- Hashemizadeh H, Noori R. Premarital screening of β thalassemia minor in north-east of Iran. Iran J Ped Hematol Oncol. 2013;3(1):210–215.
- Miri-Moghaddam E, Naderi M, Izadi S, Mashhadi M. Causes of new cases of major thalassemia in Sistan and Balouchistan Province in South-East of Iran. Iran J Public Health. 2012;41(11):67–71.
- Arif F, Fayyaz J, Hamid A. Awareness among parents of children with thalassemia major. J Pak Med Assoc. 2008;58(11):621–624.
- Karimzaei T, Masoudi Q, Shahrakipour M, et al. Knowledge, attitude and practice of carrier thalassemia marriage volunteer in prevention of major thalassemia. Glob J Health Sci. 2015;7(5):364–370.
- Waheed F, Fisher C, Awofeso A, Stanley D. Carrier screening for β-thalassemia in the Maldives: perceptions of parents of affected children who did not take part in screening and its consequences. J Community Genet. 2016;7(3):243–253.
- Greenland S, Senn SJ, Rothman KJ, et al. Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations. Eur J Epidemiol. 2016;31(4):337–350.
- Schober P, Bossers SM, Schwarte LA. Statistical significance versus clinical importance of observed effect sizes: what do p values and confidence intervals really represent? Anesth Analg. 2018;126(3):1068–1072.
- Kelley K, Preacher KJ. On effect size. Psychol Methods. 2012;17(2):137–152.
- Nakagawa S, Cuthill IC. Effect size, confidence interval and statistical significance: a practical guide for biologists. Biol Rev Camb Philos Soc. 2007;82(4):591–605.
- Schober P, Bossers SM, Dong PV, et al. What do anesthesiologists know about p values, confidence intervals, and correlations: a pilot survey. Anesthesiol Res Pract. 2017;2017:4201289.